BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 209 filers reported holding BEAM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $8,973,573 | +14.9% | 382,995 | +62.0% | 0.03% | +13.8% |
| Q1 2024 | $7,810,226 | +81.3% | 236,387 | +49.4% | 0.03% | +70.6% |
| Q4 2023 | $4,307,511 | +362.6% | 158,248 | +442.7% | 0.02% | +325.0% |
| Q2 2023 | $931,111 | -48.3% | 29,161 | -50.4% | 0.00% | -55.6% |
| Q1 2023 | $1,800,946 | +0.1% | 58,816 | +27.9% | 0.01% | -10.0% |
| Q4 2022 | $1,798,904 | -82.4% | 45,996 | -78.5% | 0.01% | -81.8% |
| Q3 2022 | $10,205,000 | -19.3% | 214,220 | -34.4% | 0.06% | -15.4% |
| Q2 2022 | $12,639,000 | +184.3% | 326,494 | +320.8% | 0.06% | +160.0% |
| Q1 2022 | $4,446,000 | +248.7% | 77,597 | +384.9% | 0.02% | +257.1% |
| Q4 2021 | $1,275,000 | +18.1% | 16,002 | +28.9% | 0.01% | 0.0% |
| Q3 2021 | $1,080,000 | -96.4% | 12,410 | -94.7% | 0.01% | -96.7% |
| Q2 2021 | $30,177,000 | +54.1% | 234,454 | -4.2% | 0.21% | +46.2% |
| Q1 2021 | $19,581,000 | +35.6% | 244,641 | +38.3% | 0.14% | +18.2% |
| Q4 2020 | $14,438,000 | – | 176,848 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,346,934 | $74,937,603 | 45.33% |
| HSG Holding Ltd | 796,089 | $25,419,122 | 2.91% |
| Deep Track Capital, LP | 1,317,316 | $42,061,900 | 1.95% |
| Redmile Group, LLC | 1,485,199 | $47,422,404 | 1.82% |
| ARK Investment Management | 8,382,595 | $267,656,246 | 1.77% |
| Casdin Capital, LLC | 570,000 | $18,200,100 | 1.59% |
| Yiheng Capital Management, L.P. | 463,800 | $14,809,134 | 0.80% |
| Temasek Holdings (Private) Ltd | 4,317,789 | $137,867,003 | 0.80% |
| Alphabet Inc. | 321,604 | $10,268,815 | 0.55% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,441,522 | $109,887,797 | 0.55% |